The Pendulum Has to Swing BackI am very hopeful that the impending announcement that TBI Open Label Trial is underway and recruiting patients, I can only imagine that the stock price will get a little shot in the arm. Remember, there haven't been any deaths resulting from this protocol and significant improvement with Stroke+Occupational Therapy.
The TBI people will be getting their Occupational Therapy in great amounts and we know that Regenesis provides good results in the 120 day time frame so it is only a matter of time before that becomes a news story.
No offense to the Indian researchers, per se, but this open label will also have the added advantage of being able to show us what a domestic study will run like without the negative assumptions of methodological hanky-panky in the Indian centers. It will also have more implied rigor to the research.
I would expect that this will precede the FDA meeting to serve a few purposes
1) generate renewed interest after this painfully dull period
2) create a springboard for the FDA news release to bounce on
3) create a net in case the FDA conclusion is not positive. (highly unlikely but still possible).
HnGrowing Bored